-
Founded in:
1997-04-28 -
Country:
China -
Address:
No. 38 Huanghe Road, Lianyungang Economic and Technological Development Zone -
Tax NO.:
9132070070404786XB -
Registered Funds:
6,379,002,274 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Mesna |
This product is a compound containing cysteine, which can combine with the toxic metabolites of repeatedly activated cyclophosphamide or ifosfamide to form non-toxic products that are quickly excreted from the body through urine, preventing urinary system damage such as hemorrhagic cystitis caused by the use of the above anticancer drugs. Because the excretion rate of this product is faster than that of cyclophosphamide, ifosfamide and their metabolites, it should be used repeatedly.
More
This product is a compound containing cysteine, which can combine with the toxic metabolites of repeatedly activated cyclophosphamide or ifosfamide to form non-toxic products that are quickly excreted from the body through urine, preventing urinary system damage such as hemorrhagic cystitis caused by the use of the above anticancer drugs. Because the excretion rate of this product is faster than that of cyclophosphamide, ifosfamide and their metabolites, it should be used repeatedly. |
19767-45-4 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Mesna |
This product is a compound containing cysteine, which can combine with the toxic metabolites of repeatedly activated cyclophosphamide or ifosfamide to form non-toxic products that are quickly excreted from the body through urine, preventing urinary system damage such as hemorrhagic cystitis caused by the use of the above anticancer drugs. Because the excretion rate of this product is faster than that of cyclophosphamide, ifosfamide and their metabolites, it should be used repeatedly.
More
This product is a compound containing cysteine, which can combine with the toxic metabolites of repeatedly activated cyclophosphamide or ifosfamide to form non-toxic products that are quickly excreted from the body through urine, preventing urinary system damage such as hemorrhagic cystitis caused by the use of the above anticancer drugs. Because the excretion rate of this product is faster than that of cyclophosphamide, ifosfamide and their metabolites, it should be used repeatedly. |
19767-45-4 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Formyl derivatives of tetrahydrofolate |
This product is a formyl derivative of tetrahydrofolate, mainly used for the rescue of high-dose methotrexate and other folic acid antagonists. It is converted into tetrahydrofolate by tetrahydrofolate reductase and can effectively counteract the toxic reaction caused by methotrexate.
More
This product is a formyl derivative of tetrahydrofolate, mainly used for the rescue of high-dose methotrexate and other folic acid antagonists. It is converted into tetrahydrofolate by tetrahydrofolate reductase and can effectively counteract the toxic reaction caused by methotrexate. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clarithromycin |
This product is a macrolide antibiotic, which has an inhibitory effect on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has an inhibitory effect on mycoplasma. In vivo, its antibacterial activity against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. It produces an antibacterial effect by hindering the association of the 50S subunit of the nucleoprotein and inhibiting protein synthesis.
More
This product is a macrolide antibiotic, which has an inhibitory effect on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has an inhibitory effect on mycoplasma. In vivo, its antibacterial activity against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. It produces an antibacterial effect by hindering the association of the 50S subunit of the nucleoprotein and inhibiting protein synthesis. |
81103-11-9 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Calcium levofolinate |
Unspecified
More
Unspecified |
80433-71-2 | 14 |